Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers: what have we achieved so far?

Administering reirradiation for the treatment of recurrent head and neck cancers is extremely challenging. These tumors are hypoxic and radioresistant and require escalated radiation doses for adequate control. The obstacle to delivering this escalated dose of radiation to the target is its proximit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bhattacharyya, Tapesh (VerfasserIn) , Koto, Masashi (VerfasserIn) , Windisch, Paul (VerfasserIn) , Ikawa, Hiroaki (VerfasserIn) , Hagiwara, Yasuhito (VerfasserIn) , Tsuji, Hiroshi (VerfasserIn) , Adeberg, Sebastian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 May 2022
In: Frontiers in oncology
Year: 2022, Jahrgang: 12, Pages: 1-13
ISSN:2234-943X
DOI:10.3389/fonc.2022.888446
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fonc.2022.888446
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fonc.2022.888446
Volltext
Verfasserangaben:Tapesh Bhattacharyya, Masashi Koto, Paul Windisch, Hiroaki Ikawa, Yasuhito Hagiwara, Hiroshi Tsuji and Sebastian Adeberg

MARC

LEADER 00000caa a2200000 c 4500
001 1809481724
003 DE-627
005 20230525084132.0
007 cr uuu---uuuuu
008 220708s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fonc.2022.888446  |2 doi 
035 |a (DE-627)1809481724 
035 |a (DE-599)KXP1809481724 
035 |a (OCoLC)1341463591 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bhattacharyya, Tapesh  |d 1981-  |e VerfasserIn  |0 (DE-588)1262093309  |0 (DE-627)1809481708  |4 aut 
245 1 0 |a Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers  |b what have we achieved so far?  |c Tapesh Bhattacharyya, Masashi Koto, Paul Windisch, Hiroaki Ikawa, Yasuhito Hagiwara, Hiroshi Tsuji and Sebastian Adeberg 
264 1 |c 23 May 2022 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.07.2022 
520 |a Administering reirradiation for the treatment of recurrent head and neck cancers is extremely challenging. These tumors are hypoxic and radioresistant and require escalated radiation doses for adequate control. The obstacle to delivering this escalated dose of radiation to the target is its proximity to critical organs at risk (OARs) and possible development of consequent severe late toxicities. With the emergence of highly sophisticated technologies, intensity-modulated radiotherapy (IMRT) and stereotactic body radiotherapy have shown promising outcomes. Proton beam radiotherapy has been used for locally recurrent head and neck cancers because of its excellent physical dose distribution, exploring sharp Bragg peak properties with negligible entrance and exit doses. To further improve these results, carbon ion radiotherapy (CIRT) has been explored in several countries across Europe and Asia because of its favorable physical properties with minimal entrance and exit doses, sharper lateral penumbra, and much higher and variable relative biological efficacy, which cannot be currently achieved with any other form of radiation. Few studies have described the role of CIRT in recurrent head and neck cancers. In this article, we have discussed the different aspects of carbon ions in reirradiation of recurrent head and neck cancers, including European and Asian experiences, different dose schedules, dose constraints of OARs, outcomes, and toxicities, and a brief comparison with proton beam radiotherapy and IMRT. 
700 1 |a Koto, Masashi  |e VerfasserIn  |4 aut 
700 1 |a Windisch, Paul  |e VerfasserIn  |4 aut 
700 1 |a Ikawa, Hiroaki  |e VerfasserIn  |4 aut 
700 1 |a Hagiwara, Yasuhito  |e VerfasserIn  |4 aut 
700 1 |a Tsuji, Hiroshi  |e VerfasserIn  |4 aut 
700 1 |a Adeberg, Sebastian  |d 1984-  |e VerfasserIn  |0 (DE-588)1049743377  |0 (DE-627)782574467  |0 (DE-576)403727774  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in oncology  |d Lausanne : Frontiers Media, 2011  |g 12(2022), Artikel-ID 888446, Seite 1-13  |h Online-Ressource  |w (DE-627)684965518  |w (DE-600)2649216-7  |w (DE-576)35841184X  |x 2234-943X  |7 nnas  |a Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers what have we achieved so far? 
773 1 8 |g volume:12  |g year:2022  |g elocationid:888446  |g pages:1-13  |g extent:13  |a Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers what have we achieved so far? 
856 4 0 |u https://doi.org/10.3389/fonc.2022.888446  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fonc.2022.888446  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220708 
993 |a Article 
994 |a 2022 
998 |g 1049743377  |a Adeberg, Sebastian  |m 1049743377:Adeberg, Sebastian  |d 910000  |d 911400  |d 50000  |e 910000PA1049743377  |e 911400PA1049743377  |e 50000PA1049743377  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 7  |y j 
999 |a KXP-PPN1809481724  |e 4162681015 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Bhattacharyya, Tapesh","family":"Bhattacharyya","given":"Tapesh","role":"aut"},{"given":"Masashi","family":"Koto","display":"Koto, Masashi","role":"aut"},{"given":"Paul","family":"Windisch","display":"Windisch, Paul","role":"aut"},{"role":"aut","given":"Hiroaki","family":"Ikawa","display":"Ikawa, Hiroaki"},{"role":"aut","display":"Hagiwara, Yasuhito","family":"Hagiwara","given":"Yasuhito"},{"role":"aut","given":"Hiroshi","display":"Tsuji, Hiroshi","family":"Tsuji"},{"given":"Sebastian","family":"Adeberg","display":"Adeberg, Sebastian","role":"aut"}],"physDesc":[{"extent":"13 S."}],"title":[{"title_sort":"Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers","title":"Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers","subtitle":"what have we achieved so far?"}],"relHost":[{"part":{"year":"2022","extent":"13","volume":"12","pages":"1-13","text":"12(2022), Artikel-ID 888446, Seite 1-13"},"title":[{"title":"Frontiers in oncology","title_sort":"Frontiers in oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Frontiers Media","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"Lausanne"}],"id":{"zdb":["2649216-7"],"issn":["2234-943X"],"eki":["684965518"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"684965518","pubHistory":["2011 -"],"note":["Gesehen am 07.11.13"],"disp":"Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers what have we achieved so far?Frontiers in oncology"}],"id":{"eki":["1809481724"],"doi":["10.3389/fonc.2022.888446"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"23 May 2022"}],"name":{"displayForm":["Tapesh Bhattacharyya, Masashi Koto, Paul Windisch, Hiroaki Ikawa, Yasuhito Hagiwara, Hiroshi Tsuji and Sebastian Adeberg"]},"note":["Gesehen am 08.07.2022"],"recId":"1809481724"} 
SRT |a BHATTACHAREMERGINGRO2320